Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615774-15-002893
Filing Date
2015-10-09
Accepted
2015-10-09 17:25:37
Documents
1
Period of Report
2015-10-01

Document Format Files

Seq Description Document Type Size
1 3 s101997_form3.html 3  
1 3 s101997_form3.xml 3 4269
  Complete submission text file 0001615774-15-002893.txt   5750
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 51 WEST 52ND STREET, 7TH FLOOR NEW YORK NY 10019
Business Address
Boenisch Sandra (Reporting) CIK: 0001655366 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51652 | Film No.: 151154005